Status: Recruiting
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
This pilot study will assess the feasibility of using an implantable microdevice to measure local intratumor response to chemotherapy and other clinically relevant drugs in ovarian, fallopian tube, and primary peritoneal cancer. The name of the study intervention involved in this study is: -implantable microdevice
Participants needed: 20
Trial details
Phase: Phase 1Age: 18+Biological sex: FemaleType: InterventionalSponsor: Brigham and Women's HospitalUpdated: May 18, 2026Locations: 2
Eligibility criteria
Participants must have suspected or confirmed clinically advanced stage (III-IV,... [+21]
Uncontrolled intercurrent illness including, but not limited to, ongoing or acti... [+3]